High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study.

Twenty patients with non-Hodgkin's lymphoma were treated with a combination of cyclophosphamide (750 mg m(-2), day 1), epidoxorubicin (60 mg m(-2), day 1), vincristine (1.4 mg m(-2), day 1) and prednisone (100 mg m(-2), days 1-5) every 14 days. Shortening of intervals was associated with the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pronzato, P., Lionetto, R., Botto, F., Pensa, F., Tognoni, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062972/
https://www.ncbi.nlm.nih.gov/pubmed/9743300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062972/
https://www.ncbi.nlm.nih.gov/pubmed/9743300

Ejemplares similares